AI assistant
Longeveron Inc. — Director's Dealing 2022
May 20, 2022
35052_dirs_2022-05-19_ea504a9f-21c7-4e9e-9485-6129207beae3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Longeveron Inc. (LGVN)
CIK: 0001721484
Period of Report: 2022-05-17
Reporting Person: Soffer Rock (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Common Stock | J | 500182 | — | Acquired | 691851 | Direct |
Footnotes
F1: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2: Shares received as part of pro rata distribution by DS Med, LLC, to its members for no consideration.
F3: Amount includes 640,098 shares of Class B Common Stock.